UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease
- PMID: 15228595
- DOI: 10.1111/j.1471-4159.2004.02485.x
UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease
Abstract
Aggresomes are associated with many neurodegenerative disorders, including Parkinson's disease, and polyglutamine disorders such as Huntington's disease. These inclusions commonly contain ubiquitylated proteins. The stage at which these proteins are ubiquitylated remains unclear. A malfunction of the ubiquitin/proteasome system (UPS) may be associated with their formation. Conversely, it may reflect an unsuccessful attempt by the cell to remove them. Previously, we demonstrated that overexpression of Parkin, a ubiquitin-protein ligase associated with autosomal recessive juvenile Parkinsonism, generates aggresome-like inclusions in UPS compromised cells. Mutations in the de-ubiquitylating enzyme, UCH-L1, cause a rare form of Parkinsonism. We now demonstrate that overexpression of UCH-L1 also forms ribbon-like aggresomes in response to proteasomal inhibition. Disease-associated mutations, which affect enzymatic activities, significantly increased the number of inclusions. UCH-L1 aggresomes co-localized with ubiquitylated proteins, HSP70, gamma-tubulin and, to a lesser extent, the 20S proteasome and the chaperone BiP. Similar to Parkin inclusions, we found UCH-L1 aggresomes to be surrounded by a tubulin rather than a vimentin cage-like structure. Furthermore, UCH-L1 aggregates with Parkin and alpha-synuclein in some, but not all inclusions, suggesting the heterogeneous nature of these inclusion bodies. This study provides additional evidence that aggregation-prone proteins are likely to recruit UPS components in an attempt to clear proteins from failing proteasomes. Furthermore, UCH-L1 accumulation is likely to play a pathological role in inclusion formation in Parkinson's disease.
Similar articles
-
Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.Mol Biol Cell. 2003 Nov;14(11):4541-56. doi: 10.1091/mbc.e03-02-0078. Epub 2003 Aug 22. Mol Biol Cell. 2003. PMID: 12937272 Free PMC article.
-
Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.Mol Biol Cell. 2001 May;12(5):1393-407. doi: 10.1091/mbc.12.5.1393. Mol Biol Cell. 2001. PMID: 11359930 Free PMC article.
-
Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.Neuroscience. 2001;104(3):901-12. doi: 10.1016/s0306-4522(01)00113-0. Neuroscience. 2001. PMID: 11440819
-
[Parkinson's disease: what have we learned from the genes responsible for familial forms?].Med Sci (Paris). 2003 May;19(5):613-9. doi: 10.1051/medsci/2003195613. Med Sci (Paris). 2003. PMID: 12836396 Review. French.
-
Pathological proteins in Parkinson's disease: focus on the proteasome.J Mol Neurosci. 2004;24(3):425-42. doi: 10.1385/JMN:24:3:425. J Mol Neurosci. 2004. PMID: 15655264 Review.
Cited by
-
Development and validation of a screening assay for the evaluation of putative neuroprotective agents in the treatment of Parkinson's disease.Neurotox Res. 2011 May;19(4):519-26. doi: 10.1007/s12640-010-9174-2. Epub 2010 Apr 2. Neurotox Res. 2011. PMID: 20361292
-
Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease.Neurotox Res. 2012 Feb;21(2):185-94. doi: 10.1007/s12640-011-9259-6. Epub 2011 Jul 20. Neurotox Res. 2012. PMID: 21773851
-
Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds.Oncoscience. 2015 May 31;2(5):457-66. doi: 10.18632/oncoscience.167. eCollection 2015. Oncoscience. 2015. PMID: 26097878 Free PMC article. Review.
-
An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?J Alzheimers Dis. 2017;60(s1):S169-S193. doi: 10.3233/JAD-170473. J Alzheimers Dis. 2017. PMID: 28800335 Free PMC article. Review.
-
A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation.J Neurochem. 2010 Apr;113(2):374-88. doi: 10.1111/j.1471-4159.2010.06592.x. Epub 2010 Feb 2. J Neurochem. 2010. PMID: 20132485 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous